A study on the diagnostic value of GP73 in liver fibrosis among patients with chronic liver disease

被引：0
|
作者：
安薪宇 [1 ]
机构：
[1] Dept Tradit & West Med Hepatol,3rd Hosp,Hebei Med Univ
来源：
ChinaMedicalAbstracts(InternalMedicine) | 2023年 / 40卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R575.2 [肝硬变];
学科分类号：
1002 ; 100201 ;
摘要：
Objective To evaluate the diagnostic value of serum Golgi protein 73 (GP73) alone and GP73 combined with liver stiffness measurement (LSM),aspartate aminotransferase/platelet ratio index (APRI),and 4-factor-based fibrosis index (FIB4) in diagnosing liver fibrosis in patients with chronic liver disease of differentetiologies.Methods A diagnostic test.
引用
收藏
页码：46 / 46
页数：1
相关论文
共 50 条
  • [31] The Diagnostic Value of FibroScan in Assessing Significant Liver Fibrosis in Patients with Chronic Hepatitis B
    Zeng, X.
    Xu, C.
    Li, M.
    Xia, J.
    Liu, M.
    Zhu, P.
    Xiang, D.
    Wang, Y.
    WEST INDIAN MEDICAL JOURNAL, 2016, 65 (01): : 106 - 110
  • [32] Value of fibrosis markers for staging liver fibrosis in patients with precirrhotic alcoholic liver disease
    Lieber, Charles S.
    Weiss, David G.
    Paronetto, Fiorenzo
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2008, 32 (06) : 1031 - 1039
  • [33] PERFORMANCE COMPARISON OF GP73, FUCOSYLATED HEMOPEXIN, PIVKA-II AND AFP IN A COHORT OF LIVER DISEASE SPECIMENS
    Hemken, P. M.
    Morota, K.
    Nakagawa, M.
    Sekiya, R.
    Sokoll, L. J.
    Elliott, D. J.
    Dowell, B. L.
    TUMOR BIOLOGY, 2010, 31 : S88 - S89
  • [34] Serum GP73, a Marker for Evaluating Progression in Patients with Chronic HBV Infections
    Wei, Hongshan
    Li, Boan
    Zhang, Renwen
    Hao, Xiaohua
    Huang, Yubo
    Qiao, Yong
    Hou, Jun
    Li, Xin
    Li, Xingwang
    PLOS ONE, 2013, 8 (02):
  • [35] Fibrosis in Chronic Liver Disease: An Update on Diagnostic and Treatment Modalities
    Manka, Paul
    Zeller, Amos
    Syn, Wing-Kin
    DRUGS, 2019, 79 (09) : 903 - 927
  • [36] Fibrosis in Chronic Liver Disease: An Update on Diagnostic and Treatment Modalities
    Paul Manka
    Amos Zeller
    Wing-Kin Syn
    Drugs, 2019, 79 : 903 - 927
  • [37] Predictive diagnostic value of bright liver and nodular liver surface in chronic liver disease.
    Palmentieri, B
    de Sio, I
    De Marino, F
    Castellano, L
    Vecchione, R
    Blanco, CD
    Torella, R
    Persico, M
    HEPATOLOGY, 2002, 36 (04) : 727A - 727A
  • [38] Serum hyaluronan: A marker of liver fibrosis in patients with chronic liver disease
    Tangkijvanich, P
    Kongtawelert, P
    Pothacharoen, P
    Mahachai, V
    Suwangool, P
    Poovorawan, Y
    ASIAN PACIFIC JOURNAL OF ALLERGY AND IMMUNOLOGY, 2003, 21 (02): : 115 - 120
  • [39] Biomarkers for the prediction of liver fibrosis in patients with chronic alcoholic liver disease
    Naveau, S
    Raynard, B
    Ratziu, V
    Abella, A
    Imbert-Bismut, F
    Messous, D
    Beuzen, F
    Capron, F
    Thabut, D
    Munteanu, M
    Chaput, JC
    Poynard, T
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2005, 3 (02) : 167 - 174
  • [40] Combining GP73 with liver stiffness measurements: A proof-of-concept for non-invasive fibrosis assessment in antiviral-naive HBV patients
    Weiskirchen, Ralf
    Tacke, Frank
    LIVER INTERNATIONAL, 2017, 37 (11) : 1605 - 1607
12345